We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
+11.02%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$234B
AUM Growth
+$2.96B
Cap. Flow
-$25.1B
Cap. Flow %
-10.74%
Top 10 Hldgs %
16.8%
Holding
6,887
New
858
Increased
2,292
Reduced
2,484
Closed
745

Top Buys

Rank Stock Value
1
IBIT icon
iShares Bitcoin Trust
IBIT
+$651M
2
FBTC icon
Fidelity Wise Origin Bitcoin Fund
FBTC
+$622M
3
MRK icon
Merck
MRK
+$496M
4
ADBE icon
Adobe
ADBE
+$446M
5
CRH icon
CRH
CRH
+$410M

Sector Composition

Rank Sector Weight
1 Technology 8.55%
2 Healthcare 6.96%
3 Financials 6.02%
4 Industrials 5.05%
5 Consumer Discretionary 4.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RFL icon
5601
Rafael Holdings
RFL
$101M
$38.8K ﹤0.01%
22,874
-5,098
-18% -$8.92K
PVLA
5602
Palvella Therapeutics
PVLA
$1.99B
$38.8K ﹤0.01%
2,647
+563
+27% +$7.84K
INAB icon
5603
IN8bio
INAB
$9.88M
$38.4K ﹤0.01%
+1,085
New +$40.9K
MRNOW
5604
CALL
Murano Global Investments PLC Warrants
MRNOW
$103K
$38.3K ﹤0.01%
+363,750
New +$49K
AUROW
5605
CALL
Aurora Innovation Warrant
AUROW
$352M
$38K ﹤0.01%
140,618
XGN icon
5606
Exagen
XGN
$109M
$37.9K ﹤0.01%
23,860
+245
+1% +$476
CENN icon
5607
Cenntro
CENN
$7.89M
$37.6K ﹤0.01%
441
-925
-68% -$74K
BSLKW
5608
CALL
DELISTED
Bolt Projects Holdings Warrant
BSLKW
$37.5K ﹤0.01%
186,328
HUMAW icon
5609
CALL
Humacyte Inc Warrant
HUMAW
$1.55M
$37.5K ﹤0.01%
62,500
KDKRW
5610
CALL
Kodiak AI Warrants
KDKRW
$37K ﹤0.01%
200,000
NKLA
5611
DELISTED
Nikola Corporation Common Stock
NKLA
$37K ﹤0.01%
1,185
-14,476
-92% -$311K
SOUNW icon
5612
CALL
SoundHound AI Warrant
SOUNW
$558M
$36K ﹤0.01%
12,250
FLDDW
5613
CALL
Fold Holdings Warrant
FLDDW
$1.22M
$35.9K ﹤0.01%
276,000
SHCR
5614
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$35.9K ﹤0.01%
46,728
-63,942
-58% -$64K
MGRM
5615
DELISTED
Monogram Orthopaedics
MGRM
$35.8K ﹤0.01%
14,652
+1,372
+10% +$4.04K
PLMJW
5616
CALL
DELISTED
Plum Acquisition Corp. III Warrant
PLMJW
$35.7K ﹤0.01%
272,446
-406,050
-60% -$56.8K
GAIA icon
5617
Gaia
GAIA
$46.8M
$35.6K ﹤0.01%
+11,571
New +$33.8K
PSFE.WS
5618
CALL
DELISTED
Paysafe Ltd Warrants
PSFE.WS
$35.5K ﹤0.01%
1,125,433
GDEVW icon
5619
CALL
GDEV Inc Warrant
GDEVW
$42.5K
$35K ﹤0.01%
500,000
PSQH.WS icon
5620
CALL
PSQ Holdings, Inc. Warrants, Each whole warrant exercisable for 1/15th of a share of Class A common stock at an exercise price of $172.50 per share
PSQH.WS
$1.63M
$35K ﹤0.01%
53,780
VAXX
5621
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
$34.6K ﹤0.01%
48,194
+5,306
+12% +$3.85K
UONE icon
5622
Urban One Class A
UONE
$22.8M
$34.3K ﹤0.01%
1,272
-123
-9% -$4.09K
FTH
5623
Faeth Therapeutics
FTH
$702M
$34.2K ﹤0.01%
1,629
-286
-15% -$4.93K
DNA.WS
5624
CALL
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$34.1K ﹤0.01%
378,619
CTSO icon
5625
Cytosorbents Corp
CTSO
$22.7M
$34.1K ﹤0.01%
35,843
-9,285
-21% -$9.04K

Similar funds

Millennium Management's Q1 2024 Portfolio in Review

As of Q1 2024, Millennium Management held 6,887 positions worth $234B, up 1.3% from $231B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Millennium Management withdrew a net $25.1B in Q1 2024, closing 745 positions and reducing 2,484 holdings. Its most notable exit was Splunk Inc, an estimated $319M position sold in full.

By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 8.3% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Millennium Management opened a new position in iShares Bitcoin Trust worth $844M.

  • Millennium Management's largest Q1 2024 buy was iShares Bitcoin Trust: 20,859,447 shares worth $844M.
  • Millennium Management added most to Merck in Q1 2024, an estimated $496M increase.
  • Millennium Management's biggest Q1 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $4.33B.
  • Millennium Management fully exited Splunk Inc in Q1 2024, selling an estimated $319M.
  • Millennium Management's ten largest holdings make up 17% of its $234B portfolio in Q1 2024.
  • Millennium Management opened 858 new positions and closed 745 in Q1 2024.
  • Millennium Management's portfolio value rose 1.3% quarter-over-quarter to $234B.

Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.